Cancer Genomics - Proteomics: 10 (1)

January-February 2013; Volume 10,Issue 1

You have access
The Intriguing Options of Multispecific Antibody Formats for Treatment of Cancer
ULRICH H. WEIDLE, GEORG TIEFENTHALER, ELISABETH H. WEISS, GUY GEORGES and ULRICH BRINKMANN

Cancer Genomics & Proteomics January 2013, 10 (1) 1-18;
You have access
Genomics and Proteomics Approaches for Biomarker Discovery in Sporadic Colorectal Cancer with Metastasis
MARÍA GONZÁLEZ-GONZÁLEZ, JACINTO GARCIA GARCIA, JOSÉ ANTONIO ALCAZAR MONTERO, LUIS MIGUEL GONZÁLEZ FERNANDEZ, OSCAR BENGOECHEA, OSCAR BLANCO MUÑEZ, ALBERTO ORFAO, J.M. SAYAGUES and MANUEL FUENTES

Cancer Genomics & Proteomics January 2013, 10 (1) 19-25;
You have access
Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
INGIRIDUR SKIRNISDOTTIR and TOMAS SEIDAL

Cancer Genomics & Proteomics January 2013, 10 (1) 27-34;
You have access
Identification by High-throughput In Silico Screening of Radio-protecting Compounds Targeting the DNA-binding Domain of the Tumor Suppressor p53
TOLGA EICHHORN, CORINNA HILLER, KERSTIN HIRSCHFELDER, MARTIN FRANK, R. LUISE KRAUTH-SIEGEL, ROLF MÜLLER, ROLF MERTENS and THOMAS EFFERTH

Cancer Genomics & Proteomics January 2013, 10 (1) 35-45;
You have access
The Differential Expression of Vascular Endothelial Growth Inhibitor Isoforms, VEGI251, VEGI174 and VEGI192 in Human Clear-cell Renal Cell Carcinoma
NING ZHANG, PENGJIE WU, LIYANG WU, DUOERKUN SHAYIREMU, HUI SHAN, LIN YE, WEN G. JIANG, KAN GONG and YONG YANG

Cancer Genomics & Proteomics January 2013, 10 (1) 47-53;

Main menu

User menu

Search

Table of Contents

In this issue